NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine Life Science Investing
Legend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T Therapy Life Science Investing
Eupraxia Pharmaceuticals Reaches its Enrollment Target for the RESOLVE Trial Investigating EP-104GI for the Treatment of Eosinophilic Esophagitis Life Science Investing
Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026 Life Science Investing
Palvella Therapeutics to Present Phase 3 SELVA and Phase 2 TOIVA Results, Along With New Pediatric Analyses, at 2026 PeDRA Annual Conference Life Science Investing
NeoGenomics Expands Indica Labs Partnership to Scale AI-Powered Digital Pathology Life Science Investing
Agility Robotics Selects Nyobolt as its Ultra-Fast Charging Battery Technology Partner for Digit 5 Life Science Investing
Roxus® ED Nasal Spray Now Available in the U.S.: Peak Blood Levels in About 10 Minutes, Not an Hour Life Science Investing
argenx to Report Third Quarter 2026 Financial Results and Business Update on October 22, 2026 Biotech Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
